Dova Pharmaceuticals Inc (DOVA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

240 LEIGH FARM ROAD DURHAM, NC 27707

Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The Company develops treatments for patients suffering from orphan diseases. Dova Pharmaceuticals focuses on acquiring, developing, and commercializing drug candidates for rare diseases. Dova Pharmaceuticals serves the healthcare sector in the United States.

Data based on most recent fiscal year report
Market Cap684.342 Million Shares Outstanding25.65 Million Avg Volume125.761 Thousand
1-Yr BETA vs S&P TR Current Ratio2.74 Quick Ratio2.74
View SEC Filings from DOVA instead.

View recent insider trading info

Funds Holding DOVA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DOVA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
16,584,802 2020-03-19 4

HOITT JASON CHIEF COMMERCIAL OFFICER

  • Officer
4,500 2020-03-19 4

JEFFS ROGER

  • Director
0 2020-03-17 3

WYSENSKI NANCY

  • Director
11,242 2020-02-24 2

SAPIR ALEX

  • Director
0 2020-02-12 0

ALLEN LEE F MD PHD CHIEF MEDICAL OFFICER

  • Officer
0 2019-11-12 4

GOLDMAN STEVEN M.

  • Director
0 2019-11-12 4

LALIBERTE KEVIN SR. VP, PRODUCT DEVELOPMENT

  • Officer
0 2019-11-12 5

NOVAK ALFRED J

  • Director
0 2019-11-12 2

STALFORT SEAN

  • Director
0 2019-11-12 1

HAHN MARK W CHIEF FINANCIAL OFFICER

  • Officer
0 2019-11-12 3

MANNING PAUL B

  • Director
  • 10% Owner
0 2019-11-12 2

ZACCARDELLI DAVID PRESIDENT & CEO

  • Officer
  • Director
0 2019-11-12 3

MANNING PAUL B

PBM CAPITAL INVESTMENTS, LLC

  • Director
  • 10% Owner
14,124,049 2017-11-09 2

BLANKENSHIP DOUGLAS CHIEF FINANCIAL OFFICER

  • Officer
0 2017-06-28 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments